17 related articles for article (PubMed ID: 38720890)
1. The Molecular Basis of Viral Inhibition of IRF- and STAT-Dependent Immune Responses.
Chiang HS; Liu HM
Front Immunol; 2018; 9():3086. PubMed ID: 30671058
[TBL] [Abstract][Full Text] [Related]
2. Interferon (IFN)-λ Takes the Helm: Immunomodulatory Roles of Type III IFNs.
Zanoni I; Granucci F; Broggi A
Front Immunol; 2017; 8():1661. PubMed ID: 29234323
[TBL] [Abstract][Full Text] [Related]
3. Differential signaling by type-I and type-III interferons in mucosa.
Stanifer ML; Boulant S
Curr Opin Immunol; 2024 Feb; 86():102400. PubMed ID: 38118395
[TBL] [Abstract][Full Text] [Related]
4. A stimulus-contingent positive feedback loop enables IFN-β dose-dependent activation of pro-inflammatory genes.
Wilder CL; Lefaudeux D; Mathenge R; Kishimoto K; Zuniga Munoz A; Nguyen MA; Meyer AS; Cheng QJ; Hoffmann A
Mol Syst Biol; 2023 May; 19(5):e11294. PubMed ID: 36929731
[TBL] [Abstract][Full Text] [Related]
5. Induction of the antiviral factors APOBEC3A and RSAD2 upon CCL2 neutralization in primary human macrophages involves NF-kB, JAK/STAT, and gp130 signaling.
Covino DA; Farina I; Catapano L; Sozzi S; Spadaro F; Cecchetti S; Purificato C; Gauzzi MC; Fantuzzi L
J Leukoc Biol; 2024 May; ():. PubMed ID: 38798090
[TBL] [Abstract][Full Text] [Related]
6. A family of conserved bacterial virulence factors dampens interferon responses by blocking calcium signaling.
Alphonse N; Wanford JJ; Voak AA; Gay J; Venkhaya S; Burroughs O; Mathew S; Lee T; Evans SL; Zhao W; Frowde K; Alrehaili A; Dickenson RE; Munk M; Panina S; Mahmood IF; Llorian M; Stanifer ML; Boulant S; Berchtold MW; Bergeron JRC; Wack A; Lesser CF; Odendall C
Cell; 2022 Jun; 185(13):2354-2369.e17. PubMed ID: 35568036
[TBL] [Abstract][Full Text] [Related]
7. HELZ2 Is an IFN Effector Mediating Suppression of Dengue Virus.
Fusco DN; Pratt H; Kandilas S; Cheon SS; Lin W; Cronkite DA; Basavappa M; Jeffrey KL; Anselmo A; Sadreyev R; Yapp C; Shi X; O'Sullivan JF; Gerszten RE; Tomaru T; Yoshino S; Satoh T; Chung RT
Front Microbiol; 2017; 8():240. PubMed ID: 28265266
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-15 in kidney disease and therapeutics.
Hall G
Curr Opin Nephrol Hypertens; 2024 Mar; 33(2):174-180. PubMed ID: 38164877
[TBL] [Abstract][Full Text] [Related]
9. Interferons and epigenetic mechanisms in training, priming and tolerance of monocytes and hematopoietic progenitors.
Mishra B; Ivashkiv LB
Immunol Rev; 2024 May; 323(1):257-275. PubMed ID: 38567833
[TBL] [Abstract][Full Text] [Related]
10. Role of type-I and type-III interferons in gastrointestinal homeostasis and pathogenesis.
Wright AP; Nice TJ
Curr Opin Immunol; 2024 Feb; 86():102412. PubMed ID: 38518661
[TBL] [Abstract][Full Text] [Related]
11. Virus infection drives IL-2 antibody complexes into pro-inflammatory agonists in mice.
Lee WW; Teo TH; Lum FM; Andiappan AK; Amrun SN; Rénia L; Rötzschke O; Ng LF
Sci Rep; 2016 Nov; 6():37603. PubMed ID: 27886209
[TBL] [Abstract][Full Text] [Related]
12. Viruses in Laboratory
Kuyateh O; Obbard DJ
Viruses; 2023 Aug; 15(9):. PubMed ID: 37766256
[No Abstract] [Full Text] [Related]
13. Macrophages treated with interferons induce different responses in lymphocytes via extracellular vesicles.
Giannessi F; Percario Z; Lombardi V; Sabatini A; Sacchi A; Lisi V; Battistini L; Borsellino G; Affabris E; Angelini DF
iScience; 2024 Jun; 27(6):109960. PubMed ID: 38832015
[TBL] [Abstract][Full Text] [Related]
14. Interleukin 27, like interferons, activates JAK-STAT signaling and promotes pro-inflammatory and antiviral states that interfere with dengue and chikungunya viruses replication in human macrophages.
Valdés-López JF; Hernández-Sarmiento LJ; Tamayo-Molina YS; Velilla-Hernández PA; Rodenhuis-Zybert IA; Urcuqui-Inchima S
Front Immunol; 2024; 15():1385473. PubMed ID: 38720890
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
